| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Mundel TM et al. | Ganglioside GM2-activator protein and vesicular transport in collecting duct intercalated cells. | 1999 | J. Am. Soc. Nephrol. | pmid:10073593 |
| Khalili-Shirazi A et al. | Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection. | 1999 | J. Neurol. Neurosurg. Psychiatry | pmid:10084538 |
| Li YT et al. | Structural basis for the resistance of Tay-Sachs ganglioside GM2 to enzymatic degradation. | 1999 | J. Biol. Chem. | pmid:10187778 |
| Mizutani K et al. | Enhancement of TNF-alpha production by ganglioside GM2 in human mononuclear cell culture. | 1999 | Neuroreport | pmid:10208534 |
| Raghavan S et al. | G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts. | 1999 | Neurochem. Res. | pmid:10227679 |
| Kemp SF and Stoolmiller AC | Biosynthesis of glycosphingolipids in cultured mouse neuroblastoma cells. Precursor-product relationships among sialoglycosphingolipids. | 1976 | J. Biol. Chem. | pmid:1033935 |
| Cavanna B et al. | Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line. | 1999 | J. Neuroimmunol. | pmid:10376949 |
| Ecsedy JA et al. | Expression of mouse sialic acid on gangliosides of a human glioma grown as a xenograft in SCID mice. | 1999 | J. Neurochem. | pmid:10386978 |
| Slevin M et al. | Physiological concentrations of gangliosides GM1, GM2 and GM3 differentially modify basic-fibroblast-growth-factor-induced mitogenesis and the associated signalling pathway in endothelial cells. | 1999 | Int. J. Cancer | pmid:10399959 |
| Fukumoto H et al. | Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo. | 1999 | Int. J. Cancer | pmid:10417777 |
| Macias A et al. | Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg). | 1999 | Hybridoma | pmid:10475241 |
| Gori AH et al. | Mediation of attachment of Burkholderia pseudomallei to human pharyngeal epithelial cells by the asialoganglioside GM1-GM2 receptor complex. | 1999 | Am. J. Trop. Med. Hyg. | pmid:10497993 |
| Zervas M and Walkley SU | Ferret pyramidal cell dendritogenesis: changes in morphology and ganglioside expression during cortical development. | 1999 | J. Comp. Neurol. | pmid:10502250 |
| Sorice M et al. | Glycosphingolipid domains on cell plasma membrane. | 1999 | Biosci. Rep. | pmid:10513897 |
| Caudie C et al. | [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. | Ann. Biol. Clin. (Paris) | pmid:10518060 | |
| Okada N and Okada H | Human IgM antibody therapy for HIV-1 infection. | 1999 | Microbiol. Immunol. | pmid:10524789 |
| Okada N et al. | Human IgM monoclonal antibody to ganglioside GM2 and complement suppress virus propagation in ex vivo cultures of lymphocytes from HIV-1 infected patients. | 1999 | Microbiol. Immunol. | pmid:10529115 |
| Zuberbier T et al. | Alterations in ganglioside expression during the differentiation of human mast cells. | 1999 | Exp. Dermatol. | pmid:10536964 |
| Nakamura K et al. | Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody. | 1999 | Cancer Res. | pmid:10537316 |
| Bierfreund U et al. | Sphingolipid hydrolases and activator proteins. | 2000 | Meth. Enzymol. | pmid:10563332 |
| Mahuran DJ | Biochemical consequences of mutations causing the GM2 gangliosidoses. | 1999 | Biochim. Biophys. Acta | pmid:10571007 |
| Holmgren J et al. | Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. | 1975 | Proc. Natl. Acad. Sci. U.S.A. | pmid:1058471 |
| Pospisil M et al. | Cancer immunomodulation by carbohydrate ligands for the lymphocyte receptor NKR-P1. | 2000 | Int. J. Oncol. | pmid:10639569 |
| Brezicka T et al. | Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues. | 2000 | Lung Cancer | pmid:10704706 |
| Ang CW et al. | Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits. | 2000 | J. Neuroimmunol. | pmid:10713352 |
| Chapman PB et al. | Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study. | 2000 | Clin. Cancer Res. | pmid:10741710 |
| Ang CW et al. | Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome. | 2000 | Neurology | pmid:10751257 |
| Tsurifune T et al. | Alteration of tumor phenotypes of B16 melanoma after genetic remodeling of the ganglioside profile. | 2000 | Int. J. Oncol. | pmid:10853034 |
| Kosanke SD et al. | Clinical and biochemical abnormalities in porcine GM2-gangliosidosis. | 1978 | Vet. Pathol. | pmid:108843 |
| Wu X et al. | The IgM antibody level against ganglioside GM2 correlates to the disease status of HIV-1-infected patients. | 2000 | Microbiol. Immunol. | pmid:10888361 |
| Kolter T et al. | Recent advances in the biochemistry of glycosphingolipid metabolism. | 1999 | Biochem. Soc. Trans. | pmid:10917612 |
| Portoukalian J | Immunogenicity of glycolipids. | 2000 | Clin Rev Allergy Immunol | pmid:11064828 |
| Chiavegatto S et al. | A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice. | 2000 | Exp. Neurol. | pmid:11085888 |
| Chapman PB et al. | Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine: a trial comparing doses of G(D2)-keyhole limpet hemocyanin. | 2000 | Clin. Cancer Res. | pmid:11156217 |
| Mattson MP | New blood cells help an overburdened brain. | 2001 | Trends Neurosci. | pmid:11163874 |
| Kaida K et al. | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | 2001 | J. Neuroimmunol. | pmid:11164910 |
| Zervas M et al. | Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. | 2001 | J. Neuropathol. Exp. Neurol. | pmid:11202175 |
| Kirkwood JM et al. | High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696. | 2001 | J. Clin. Oncol. | pmid:11230488 |
| Cavanna B et al. | Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies. | 2001 | J. Neuroimmunol. | pmid:11240036 |
| Ang CW et al. | Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits. | 2001 | Infect. Immun. | pmid:11254608 |
| Parajuli P et al. | Humanized anti-ganglioside GM2 antibody is effective to induce antibody-dependent cell-mediated cytotoxicity in mononuclear cells from lung cancer patients. | 2001 | Cancer Lett. | pmid:11275367 |
| Werth N et al. | Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids. | 2001 | J. Biol. Chem. | pmid:11278374 |
| Kirkwood JM et al. | High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. | 2001 | J. Clin. Oncol. | pmid:11331315 |
| Yoshida S et al. | Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. | 2001 | Cancer Res. | pmid:11358851 |
| Saito M and Sugiyama K | Gangliosides in rat kidney: composition, distribution, and developmental changes. | 2001 | Arch. Biochem. Biophys. | pmid:11360994 |
| Nakamura K et al. | Dissection and optimization of immune effector functions of humanized anti-ganglioside GM2 monoclonal antibody. | 2000 | Mol. Immunol. | pmid:11399321 |
| Op Den Velde W and Hooghwinkel GJ | The brain ganglioside pattern in presenile and senile dementia. | 1975 | J Am Geriatr Soc | pmid:1141629 |
| Hedberg KM et al. | Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro. | 2000 | Glycoconj. J. | pmid:11425192 |
| Hanibuchi M et al. | Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966. | 2000 | Clin. Exp. Metastasis | pmid:11467766 |
| Sueyoshi N et al. | Apoptosis of Neuro2a cells induced by lysosphingolipids with naturally occurring stereochemical configurations. | 2001 | J. Lipid Res. | pmid:11483620 |
| pmid:11495348 | ||||
| Beccari T et al. | Promoter characterization and expression of the gene coding for the human GM2 activator protein. | 2001 | Biosci. Rep. | pmid:11508694 |
| Ortiz N et al. | IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release. | 2001 | J. Neuroimmunol. | pmid:11525808 |
| Teixeira CA et al. | Retrovirus-mediated transfer and expression of beta-hexosaminidase alpha-chain cDNA in human fibroblasts from G(M2)-gangliosidosis B1 variant. | 2001 | Hum. Gene Ther. | pmid:11560770 |
| Taniguchi M et al. | Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann-Pick disease type C mouse brain. | 2001 | Brain Dev. | pmid:11578853 |
| Li SC et al. | Evidence for the presence of two separate protein activators for the enzymic hydrolysis of GM1 and GM2 gangliosides. | 1979 | J. Biol. Chem. | pmid:115863 |
| Li SC et al. | Degradation of G(M1) and G(M2) by mammalian sialidases. | 2001 | Biochem. J. | pmid:11696012 |
| Gouni-Berthold I et al. | Gangliosides GM1 and GM2 induce vascular smooth muscle cell proliferation via extracellular signal-regulated kinase 1/2 pathway. | 2001 | Hypertension | pmid:11711493 |
| Guerry P et al. | Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. | 2002 | Infect. Immun. | pmid:11796612 |
| Miljan EA et al. | Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. | 2002 | J. Biol. Chem. | pmid:11796728 |
| Mehta RR et al. | In vitro transformation of human congenital naevus to malignant melanoma. | 2002 | Melanoma Res. | pmid:11828255 |
| Sango K et al. | Lysosomal storage results in impaired survival but normal neurite outgrowth in dorsal root ganglion neurones from a mouse model of Sandhoff disease. | 2002 | Neuropathol. Appl. Neurobiol. | pmid:11849560 |
| Martino S et al. | Absence of metabolic cross-correction in Tay-Sachs cells: implications for gene therapy. | 2002 | J. Biol. Chem. | pmid:11923278 |
| Alaedini A et al. | Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay. | 2002 | J. Neurol. Sci. | pmid:11959155 |
| Myerowitz R et al. | Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. | 2002 | Hum. Mol. Genet. | pmid:12019216 |
| Trindade VM et al. | Ganglioside alterations in the central nervous system of rats chronically injected with methylmalonic and propionic acids. | 2002 | Metab Brain Dis | pmid:12083341 |
| Lopate G et al. | Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies. | 2002 | Muscle Nerve | pmid:12115971 |
| Gadola SD et al. | Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. | 2002 | Nat. Immunol. | pmid:12118248 |
| Niazi KR et al. | The CD1b structure: antigen presentation adapts to a high-fat diet. | 2002 | Nat. Immunol. | pmid:12145652 |
| Jeyakumar M et al. | An inducible mouse model of late onset Tay-Sachs disease. | 2002 | Neurobiol. Dis. | pmid:12270683 |
| Jeyakumar M et al. | Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis. | 2002 | Neuropathol. Appl. Neurobiol. | pmid:12366816 |
| Ravasi D et al. | Study of interaction of GM2 activator protein with GM2 using circular dichroism and fluorescence spectroscopy. | 2002 | Neurochem. Res. | pmid:12374214 |
| Martino S et al. | Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model. | 2002 | Neurochem. Res. | pmid:12374215 |
| Wölfl M et al. | Gangliosides inhibit the development from monocytes to dendritic cells. | 2002 | Clin. Exp. Immunol. | pmid:12452834 |
| Chen HH et al. | Suppression of lung metastasis of mouse Lewis lung cancer P29 with transfection of the ganglioside GM2/GD2 synthase gene. | 2003 | Int. J. Cancer | pmid:12455030 |
| Sharma R et al. | A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside. | 2003 | Biochim. Biophys. Acta | pmid:12527415 |
| Shimada Y et al. | Effect of GM2 activator protein on the enzymatic hydrolysis of phospholipids and sphingomyelin. | 2003 | J. Lipid Res. | pmid:12576516 |
| Rapoport E et al. | Ganglioside binding pattern of CD33-related siglecs. | 2003 | Bioorg. Med. Chem. Lett. | pmid:12639556 |
| Yamaguchi A et al. | Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease. | 2003 | J. Mol. Med. | pmid:12682727 |
| Odaka M and Yuki N | Antibodies to GM2 ganglioside in neurological disorders. | 2003 | Intern. Med. | pmid:12705785 |
| Mizutani K et al. | Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2. | 2003 | Intern. Med. | pmid:12705795 |
| Antoine T et al. | Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli. | 2003 | Chembiochem | pmid:12740812 |
| Pelled D et al. | Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. | 2003 | J. Biol. Chem. | pmid:12756243 |
| Li YT et al. | Presence of an unusual GM2 derivative, taurine-conjugated GM2, in Tay-Sachs brain. | 2003 | J. Biol. Chem. | pmid:12829702 |
| Irie S et al. | Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA. | 2003 | Intern. Med. | pmid:12857046 |
| Schaeper RJ et al. | In vitro biosynthesis of GbOse4Cer (globoside) and GM2 ganglioside by the (1-->3) and (1-->4)-N-acetyl beta-D-galactosaminyltransferases from embryonic chicken brain. Solubilization, purification, and characterization of the transferases. | 1992 | Carbohydr. Res. | pmid:1291049 |
| Tada M et al. | [Steroid-pulse therapy in Guillain-Barré syndrome associated with cytomegalovirus infection: a case report]. | 2003 | No To Shinkei | pmid:12910997 |
| Brown ER and Ibrahim JG | A Bayesian semiparametric joint hierarchical model for longitudinal and survival data. | 2003 | Biometrics | pmid:12926706 |
| Obi T et al. | IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polysialogangliosides. | 1992 | Acta Neurol. Scand. | pmid:1384262 |
| Renshaw PF et al. | Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis. | 1992 | Ann. Neurol. | pmid:1386210 |
| O'Brien JS et al. | Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts. | 1977 | Clin. Genet. | pmid:13950 |
| SAIFER A et al. | CHROMATOGRAPHIC STUDIES OF NORMAL AND TAY-SACHS GANGLIOSIDES (PEPTIDE-STRANDIN). | 1963 | J. Neurochem. | pmid:14062003 |
| Xie B et al. | Identification of a processed pseudogene related to the functional gene encoding the GM2 activator protein: localization of the pseudogene to human chromosome 3 and the functional gene to human chromosome 5. | 1992 | Genomics | pmid:1427911 |
| Mauri L et al. | Procedure for separation of GM2 ganglioside species with different ceramide structures by a flash reversed-phase silica gel liquid chromatography. | 2003 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:14552811 |
| Li YT et al. | Structural basis for the enzymatic resistance of the GM2 ganglioside. | 2003 | Meth. Enzymol. | pmid:14579580 |
| Wendeler M et al. | Recombinant ganglioside GM2 synthase--expression in insect cells and enzyme assay. | 2003 | Meth. Enzymol. | pmid:14579597 |
| Yamaguchi A et al. | Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses. | 2004 | J. Clin. Invest. | pmid:14722612 |
| Wendeler M et al. | Photoaffinity labelling of the human GM2-activator protein. Mechanistic insight into ganglioside GM2 degradation. | 2004 | Eur. J. Biochem. | pmid:14728689 |
| Batuwangala T et al. | The crystal structure of human CD1b with a bound bacterial glycolipid. | 2004 | J. Immunol. | pmid:14764708 |
Ganglioside GM2
Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.
Cross Reference
Introduction
To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Ganglioside GM2?
Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Ganglioside GM2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Ganglioside GM2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Ganglioside GM2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Ganglioside GM2?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Ganglioside GM2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Ganglioside GM2?
Disease model
Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.